SOUTH SAN FRANCISCO, Calif., April 3, 2018—Biocompare, the leading online information resource for the life sciences, just released its 2018 Immunoassay Market Report.
This comprehensive report provides a detailed analysis of the immunoassay market including market share and vendor preferences. It’s based on a recently conducted survey of over 700 scientists from academia, biotech/pharma, and hospital/clinical labs.
In addition to the market overview and analysis, the report includes data on immunoassay techniques and platforms utilized, emerging trends, products used, and the companies that supply the products—including reagents and instruments—for each technique. Survey participants also candidly discussed their workflows and the challenges they face with immunoassay techniques. The survey concluded with respondents weighing in on how suppliers designing immunoassay instruments and reagents can improve their products.
The most frequently voiced recommendations centered around affordability, ease of use, better technical support, and reproducibility. ELISA comments dominated the verbatim section, which was not surprising considering that ELISA is the most widely conducted immunoassay procedure, according to Biocompare’s survey. Its popularity is driven in part by its reliability, sensitivity, and accuracy. Leading ELISA companies mentioned by survey participants included Abcam, Thermo Fisher Scientific, and R&D Systems.
The top five areas of immunoassay research were identified in the survey as immunology, molecular biology, cell biology, biochemistry, and cell signaling. When asked what their primary purpose was for performing immunoassays, respondents’ answers varied from biomarker development to infectious disease testing.
Cytokines and growth factors were far and away the top analyte types measured using immunoassays, with cell surface and intracellular markers also appearing in the top-ten analytes measured, according to survey respondents.
No matter the sample type (serum, plasma, cell lysate, etc), humans were the top species being studied, followed by mouse. For most sample types, rat rounded out the top-three species being studied.
The 2018 Immunoassay Market Report is the latest in Biocompare’s Surveys and Reports series. The biennial Antibody Market Report was released in September 2017, and a Flow Cytometry Market Report was released in September 2016.
More information on the 2018 Immunoassay Market Report is available here
About Biocompare
Headquartered in South San Francisco, California, Biocompare is a subsidiary of CompareNetworks, Inc., a company focused on empowering life scientists and healthcare professionals with a digital marketplace to enhance their productivity. Biocompare provides a platform for connecting the buyers, users, and sellers of life science products. By combining an in-depth knowledge of life science technologies with the power of the Internet, Biocompare offers a dynamic, relevant, and innovative media-based marketplace for life science information.
Contact Tamlyn Oliver (toliver@biocompare.com) for more information.